For the week of October 17, 2025, two significant updates have been announced: the FDA approval of a new blood test for detecting Alzheimer’s disease and the delay in the 2026 cost-of-living adjustment due to the government shutdown.
A new blood test has been approved by the FDA to detect Alzheimer’s disease, marking a significant advancement in medical technology.
The government shutdown has caused a delay in the announcement of the 2026 cost-of-living adjustment.
A different privacy policy and terms of service will apply when leaving AARP.org.
Author's summary: New Alzheimer's test approved.